Emergent Biosolutions (EBS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2010 | 12-2009 | 12-2008 | 12-2007 | 12-2006 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 47,184 | 26,545 | 19,958 | 22,936 | 22,793 |
| Depreciation Amortization | 5,990 | 4,999 | 4,964 | 4,817 | 4,715 |
| Income taxes - deferred | 9,229 | 5,752 | 2,006 | 5,589 | 987 |
| Accounts receivable | 19,094 | -30,017 | -6,038 | 24,514 | -40,801 |
| Accounts payable and accrued liabilities | 3,392 | -1,547 | -457 | -12 | 7,105 |
| Other Working Capital | 22,957 | -25,185 | -21,374 | 25,543 | -32,517 |
| Other Operating Activity | -9,825 | 49,323 | 8,258 | -27,940 | 33,657 |
| Operating Cash Flow | $98,021 | $29,870 | $7,317 | $55,447 | $-4,061 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 6,518 | 0 | N/A | N/A | N/A |
| PPE Investments | -22,101 | -33,287 | -20,813 | -43,969 | -41,228 |
| Net Acquisitions | -17,873 | N/A | N/A | N/A | -218 |
| Other Investing Activity | 10,000 | 0 | -10,000 | 0 | 0 |
| Investing Cash Flow | $-23,456 | $-33,287 | $-30,813 | $-43,969 | $-41,446 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 15,000 | 57,183 | 60,000 | 33,195 | 32,430 |
| Debt Repayment | -33,291 | -48,648 | -60,751 | -18,015 | -1,569 |
| Common Stock Issued | 7,235 | 4,464 | 3,391 | 2,471 | 54,819 |
| Common Stock Repurchased | 0 | N/A | N/A | N/A | -192 |
| Other Financing Activity | 2,607 | 1,845 | 6,328 | 840 | 340 |
| Financing Cash Flow | $-8,449 | $14,844 | $8,968 | $18,491 | $85,828 |
| Exchange Rate Effect | -21 | 24 | 271 | -657 | -197 |
| Beginning Cash Position | 102,924 | 91,473 | 105,730 | 76,418 | 36,294 |
| End Cash Position | 169,019 | 102,924 | 91,473 | 105,730 | 76,418 |
| Net Cash Flow | $66,095 | $11,451 | $-14,257 | $29,312 | $40,124 |
| Free Cash Flow | |||||
| Operating Cash Flow | 98,021 | 29,870 | 7,317 | 55,447 | -4,061 |
| Capital Expenditure | -22,101 | -33,287 | -20,813 | -43,969 | -41,228 |
| Free Cash Flow | 75,920 | -3,417 | -13,496 | 11,478 | -45,289 |